Improved Biochemical Outcomes With Statin Use in Patients With High-Risk Localized Prostate Cancer Treated With Radiotherapy
- 1 March 2011
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 79 (3), 713-718
- https://doi.org/10.1016/j.ijrobp.2009.12.006
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Statins and the Risk of Colorectal CancerNew England Journal of Medicine, 2005
- Therapy Insight: potential of statins for cancer chemoprevention and therapyNature Clinical Practice Oncology, 2005
- Effects of statins and farnesyltransferase inhibitors on the development and progression of cancerCancer Treatment Reviews, 2004
- Statin use and cancer risk in the General Practice Research DatabaseBritish Journal of Cancer, 2004
- Inhibition of cdk2 Activating Phosphorylation by MevastatinPublished by Elsevier BV ,2003
- HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosisLeukemia, 2002
- Lovastatin-induced E2F-1 modulation and its effect on prostate cancer cell death.Carcinogenesis: Integrative Cancer Research, 2001
- 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors and the Risk of CancerArchives of Internal Medicine, 2000
- Signaling Molecules Derived from the Cholesterol Biosynthetic PathwayPublished by Springer Science and Business Media LLC ,1997
- Regulation of the mevalonate pathwayNature, 1990